Literature DB >> 29666808

Oncological outcomes of the TIME trial in esophageal cancer: is it the era of minimally invasive esophagectomy?

Lijie Tan1, Han Tang1.   

Abstract

Entities:  

Year:  2018        PMID： 29666808      PMCID： PMC5890031          DOI： 10.21037/atm.2017.10.30

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  13 in total

1.  Outcomes after minimally invasive esophagectomy: review of over 1000 patients.

Authors:  James D Luketich; Arjun Pennathur; Omar Awais; Ryan M Levy; Samuel Keeley; Manisha Shende; Neil A Christie; Benny Weksler; Rodney J Landreneau; Ghulam Abbas; Matthew J Schuchert; Katie S Nason
Journal:  Ann Surg       Date:  2012-07       Impact factor: 12.969

2.  Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.

Authors:  Luis F Tapias; Douglas J Mathisen; Cameron D Wright; John C Wain; Henning A Gaissert; Ashok Muniappan; Michael Lanuti; Dean M Donahue; Christopher R Morse
Journal:  Ann Thorac Surg       Date:  2015-12-01       Impact factor: 4.330

3.  The 3-Hole Minimally Invasive Esophagectomy: A Safe Procedure Following Neoadjuvant Chemotherapy and Radiation.

Authors:  Rona Spector; Yifan Zheng; Beow Y Yeap; Jon O Wee; Abraham Lebenthal; Scott J Swanson; David E Marchosky; Peter C Enzinger; Harvey J Mamon; Antoon Lerut; Robert Odze; Amitabh Srivastava; Agoston T Agoston; Mingkhwan Tippayawang; Raphael Bueno
Journal:  Semin Thorac Cardiovasc Surg       Date:  2015-06-20

4.  Learning curve to lymph node resection in minimally invasive esophagectomy for cancer.

Authors:  Ankit Dhamija; Joshua E Rosen; Anish Dhamija; Bonnie E Gould Rothberg; Anthony W Kim; Frank C Detterbeck; Daniel J Boffa
Journal:  Innovations (Phila)       Date:  2014 Jul-Aug

5.  Worldwide incidence, mortality and time trends for cancer of the oesophagus.

Authors:  Bhawna Gupta; Narinder Kumar
Journal:  Eur J Cancer Prev       Date:  2017-03       Impact factor: 2.497

6.  Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Population-Based Analysis.

Authors:  Babatunde A Yerokun; Zhifei Sun; Chi-Fu Jeffrey Yang; Brian C Gulack; Paul J Speicher; Mohamed A Adam; Thomas A D'Amico; Mark W Onaitis; David H Harpole; Mark F Berry; Matthew G Hartwig
Journal:  Ann Thorac Surg       Date:  2016-05-04       Impact factor: 4.330

7.  Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial.

Authors:  Surya S A Y Biere; Mark I van Berge Henegouwen; Kirsten W Maas; Luigi Bonavina; Camiel Rosman; Josep Roig Garcia; Suzanne S Gisbertz; Jean H G Klinkenbijl; Markus W Hollmann; Elly S M de Lange; H Jaap Bonjer; Donald L van der Peet; Miguel A Cuesta
Journal:  Lancet       Date:  2012-05-01       Impact factor: 79.321

8.  Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Comparison of Early Surgical Outcomes From The Society of Thoracic Surgeons National Database.

Authors:  Smita Sihag; Andrzej S Kosinski; Henning A Gaissert; Cameron D Wright; Paul H Schipper
Journal:  Ann Thorac Surg       Date:  2015-12-17       Impact factor: 4.330

9.  Minimally invasive Ivor Lewis esophagectomy: description of a learning curve.

Authors:  Luis F Tapias; Christopher R Morse
Journal:  J Am Coll Surg       Date:  2014-02-21       Impact factor: 6.113

10.  Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer, a randomized controlled trial (ROBOT trial).

Authors:  Pieter C van der Sluis; Jelle P Ruurda; Sylvia van der Horst; Roy J J Verhage; Marc G H Besselink; Margriet J D Prins; Leonie Haverkamp; Carlo Schippers; Inne H M Borel Rinkes; Hans C A Joore; Fiebo Jw Ten Kate; Hendrik Koffijberg; Christiaan C Kroese; Maarten S van Leeuwen; Martijn P J K Lolkema; Onne Reerink; Marguerite E I Schipper; Elles Steenhagen; Frank P Vleggaar; Emile E Voest; Peter D Siersema; Richard van Hillegersberg
Journal:  Trials       Date:  2012-11-30       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.